Nanosphere Health Sciences (STU:2CG2) EV-to-Revenue : (As of Jun. 02, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Nanosphere Health Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nanosphere Health Sciences's enterprise value is €0.25 Mil. Nanosphere Health Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil. Therefore, Nanosphere Health Sciences's EV-to-Revenue for today is .

The historical rank and industry rank for Nanosphere Health Sciences's EV-to-Revenue or its related term are showing as below:

During the past 13 years, the highest EV-to-Revenue of Nanosphere Health Sciences was 1577.45. The lowest was -81.62. And the median was -5.16.

STU:2CG2's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.39
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Nanosphere Health Sciences's stock price is €0.0165. Nanosphere Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00. Therefore, Nanosphere Health Sciences's PS Ratio for today is .

Nanosphere Health Sciences EV-to-Revenue Historical Data

The historical data trend for Nanosphere Health Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences EV-to-Revenue Chart

Nanosphere Health Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

Nanosphere Health Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Nanosphere Health Sciences's EV-to-Revenue

For the Biotechnology subindustry, Nanosphere Health Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosphere Health Sciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Nanosphere Health Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nanosphere Health Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.254	/	0
	=

Nanosphere Health Sciences's current Enterprise Value is €0.25 Mil.
Nanosphere Health Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Nanosphere Health Sciences (STU:2CG2) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nanosphere Health Sciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0165	/	0
	=

Nanosphere Health Sciences's share price for today is €0.0165.
Nanosphere Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

Nanosphere Health Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosphere Health Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (STU:2CG2) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

NSHSF:USA NSHS:Canada

Address

605 Robson Street, c/o Suite 430, Vancouver, BC, CAN, V6B 5J3

Website

http://www.nanospherehealth.com

Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of biologically active compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicaments through licensing arrangements.

Nanosphere Health Sciences Headlines

No Headlines